|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Protagonist Therapeutics (NASDAQ: PTGX) through any online brokerage.
The latest price target for Protagonist Therapeutics (NASDAQ: PTGX) was reported by Northland Capital Markets on May 24, 2021. The analyst firm set a price target for 42.00 expecting PTGX to fall to within 12 months (a possible -10.68% downside). 7 analyst firms have reported ratings in the last year.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $47.02 last updated Fri Jul 23 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Protagonist Therapeutics.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.